Nazareno Gonzalez

6PUBLICATIONS
27CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsImmunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2025
RIPK1 in Diffuse Glioma Pathology: From Prognosis Marker to Potential Therapeutic Target.

Leslie C Amorós Morales, Santiago M Gómez Bergna, Abril Marchesini

|Jun 26, 2025
Integrated Workflow for Drug Repurposing in Glioblastoma: Computational Prediction and Preclinical Validation of Therapeutic Candidates.

Nazareno Gonzalez, Melanie Pérez Küper, Matías Garcia Fallit

|Dec 14, 2021
Potential of IDH mutations as immunotherapeutic targets in gliomas: a review and meta-analysis.

Nazareno Gonzalez, Antonela S Asad, José Gómez Escalante

|Sep 23, 2020
VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma.

L Francisco Lorenzo-Martín, Natalia Fernández-Parejo, Mauricio Menacho-Márquez

|Sep 08, 2020
The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?

Antonela S Asad, Alejandro J Nicola Candia, Nazareno Gonzalez

|Dec 22, 2019
Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.

Antonela Sofía Asad, Alejandro Javier Nicola Candia, Nazareno Gonzalez

Pageof 1

Frequent Collaborators

4 joint publications

Marianela Candolfi

3 joint publications

Adriana Seilicovich

3 joint publications

Alejandro Nicola Candia

2 joint publications

Antonela S Asad